Impact of COVID-19 Public Health Measures on Antiretroviral Therapy Use Among Ugandans Living with HIV in Sero-Different Couples
AIDS and Behavior · 2025
DOI: 10.1007/s10461-025-04612-2 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift AIDS and Behavior, 2025. Verfasst von Timothy R Muwonge und 15 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Institute, Makerere University, Kampala, Uganda. Hauptthemen laut MEDLINE: Anti-HIV Agents, COVID-19, HIV Infections, East African People. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, National Institute of Mental Health.
Abstract (Originalsprache)
Antiretroviral therapy (ART) use and HIV suppression among people living with HIV (PLHIV) are critical for HIV control and prevention. Extreme restrictions on movement early during the COVID-19 pandemic in Uganda may have impeded the ability to initiate and sustain access to and use of ART. From our stepped-wedge cluster-randomized trial of an integrated PrEP and ART intervention for HIV-serodifferent couples at 12 ART clinics in Uganda, we identified participants who enrolled and had a 6-month post-ART initiation viral load measured before the beginning of the first COVID-19 lockdown (Period 1), participants whose enrollment and 6-month viral load measurement straddled pre-COVID and COVID lockdown times (Period 2), and participants whose enrollment and 6-month viral load were quantified entirely during COVID-19 (Period 3). ART and viral load data were abstracted from standard-of-care HIV clinic records. We used adjusted generalized estimating equation models to compare viral suppression between the different periods. We enrolled 1,381 PLHIV, including 896 (64.9%) in Period 1, 260 (18.8%) in Period 2, and 225 (16.3%) in Period 3. Almost all (1371, 99.3%) initiated ART within 90 days of enrollment and 59.2% had baseline CD4 > 350 cells/mm 3 . Among those enrolled, 88.8% of participants in Period 1 were virally suppressed (< 1000 copies/mL) within six months of ART initiation, 80.5% in Period 2, and 88.2% in Period 3. All pairwise comparisons demonstrated statistically similar levels of viral suppression. Despite COVID-19 lockdown measures, PLHIV in serodifferent partnerships successfully initiated ART and attained and maintained viral suppression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Institute, Makerere University, Kampala, Uganda.
- Department of Global Health, University of Washington, Seattle, WA, USA.
- Department of Psychology, University of Washington, Seattle, WA, USA.
- CharacterStrong LLC Seattle, Washington, USA.
- Brigham and Women's Hospital, Boston, MA, USA.
- Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Förderung
- NIMH NIH HHS
- National Institute of Mental Health
Zitieren
APA
Muwonge, T. R., Feutz, E., Nsubuga, R., Simoni, J. M., Nambi, F., Nakabugo, L., Namanda, S., Kibuuka, J., Thomas, D., Katz, I. T., Thomas, K. K., Ware, N. C., Wyatt, M. A., Kadama, H., Mujugira, A., & Heffron, R. (2025). Impact of COVID-19 Public Health Measures on Antiretroviral Therapy Use Among Ugandans Living with HIV in Sero-Different Couples. AIDS and Behavior. https://doi.org/10.1007/s10461-025-04612-2
Vancouver
Muwonge TR, Feutz E, Nsubuga R, Simoni JM, Nambi F, Nakabugo L, et al. Impact of COVID-19 Public Health Measures on Antiretroviral Therapy Use Among Ugandans Living with HIV in Sero-Different Couples. AIDS and Behavior. 2025. doi:10.1007/s10461-025-04612-2
BibTeX
@article{Muwonge2025,
author = {Muwonge, Timothy R and Feutz, Erika and Nsubuga, Rogers and Simoni, Jane M and Nambi, Florence and Nakabugo, Lylianne and Namanda, Sylvia and Kibuuka, Joseph and Thomas, Dorothy and Katz, Ingrid T and Thomas, Katherine K and Ware, Norma C and Wyatt, Monique A and Kadama, Herbert and Mujugira, Andrew and Heffron, Renee},
title = {Impact of COVID-19 Public Health Measures on Antiretroviral Therapy Use Among Ugandans Living with HIV in Sero-Different Couples},
journal = {AIDS and Behavior},
year = {2025},
doi = {10.1007/s10461-025-04612-2}
}
EUVIMED